News & Events

In the US Food and Drug Administration Amendments Act of 2007, the Food and Drug Administration (FDA) was mandated to establish a postmarket active risk identification and analysis (ARIA) system…

Valsartan, Losartan and Irbesartan Use in the USA, UK, Canada and Denmark After the Nitrosamine Recalls: A Descriptive Cohort Study

Publication

04/17/2023

We sought to examine valsartan, losartan and irbesartan usage and switching patterns in the United States of America, United Kingdom, Canada and Denmark before and after July 2018, when the first…

View All

Recent Sentinel Activity

Leveraging Missing Data and Measurement Error Approaches in Propensity Score-Based Analyses of Real-World Data

08/21/2023
Sentinel Initiative Events
Multi-wave Validation Sampling to Improve Estimates Derived from Electronic Health Record Data

07/11/2023
Sentinel Initiative Events
New Molecular Entities (NMEs) & Utilization Characterization

05/30/2023
Studies

View All Recent Activity

Meetings, Workshops & Trainings

FDA Safety Communications

FDA Advisory Committee Meetings

Latest Publications & Presentations

Recent Sentinel Activity

Leveraging Missing Data and Measurement Error Approaches in Propensity Score-Based Analyses of Real-World Data

Multi-wave Validation Sampling to Improve Estimates Derived from Electronic Health Record Data

New Molecular Entities (NMEs) & Utilization Characterization